Fibrogen Stock In The News
| FGEN Stock | USD 1.05 0.03 2.94% |
The tone or emotional content of news articles related to FibroGen can affect its prices. Positive news sentiment can lead to an increase in demand for FibroGen's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of FibroGen's news coverage and content from conventional and social sources shows investors' bearish mood towards FibroGen. The specific impact of FibroGen news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of FibroGen's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using FibroGen headlines in addition to utilizing other, more conventional financial analysis modules. Check out FibroGen Backtesting and FibroGen Hype Analysis. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.
FibroGen |
FibroGen Today Top News and Investor Outlook
FibroGen Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide FibroGen and other traded companies coverage. We help investors stay connected with FibroGen headlines for the 26th of April to make an informed investment decision based on correlating the impacts of news items on FibroGen Stock performance. Please note that trading solely based on the FibroGen hype is not for everyone as timely availability and quick action are needed to avoid losses.FibroGen stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the FibroGen earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about FibroGen that are available to investors today. That information is available publicly through FibroGen media outlets and privately through word of mouth or via FibroGen internal channels. However, regardless of the origin, that massive amount of FibroGen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of FibroGen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of FibroGen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to FibroGen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive FibroGen alpha.
FibroGen Largest EPS Surprises
Earnings surprises can significantly impact FibroGen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-05-10 | 2021-03-31 | -0.87 | -0.78 | 0.09 | 10 | ||
2015-08-13 | 2015-06-30 | 0.73 | 0.83 | 0.1 | 13 | ||
2016-05-09 | 2016-03-31 | -0.56 | -0.45 | 0.11 | 19 | ||
2017-11-08 | 2017-09-30 | -0.37 | -0.5 | -0.13 | 35 | ||
2019-05-09 | 2019-03-31 | -0.67 | -0.53 | 0.14 | 20 | ||
2024-02-26 | 2023-12-31 | -0.42 | -0.57 | -0.15 | 35 |
FibroGen Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to FibroGen Stock. The global stock market is bearish. About 63% of major world exchanges and indexes are down. See today's market update for more information.
24th of April 2024
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 in Combina... at finance.yahoo.com
22nd of April 2024
Disposition of 300000 shares by Adib Deyaa of FibroGen at 1.71 subject to Rule 16b-3 at MacroaxisInsider
18th of April 2024
DiaMedica Up as Stroke Study Dosing Begins Post Relaunch at finance.yahoo.com
15th of April 2024
Acquisition by Juan Graham of 120000 shares of FibroGen subject to Rule 16b-3 at MacroaxisInsider
12th of April 2024
RallyBio Partners With JJ Gets 6.6M Funding, Stock Up at finance.yahoo.com
3rd of April 2024
Evaxion Up on Upbeat Preclinical S. Aureus Vaccine Data at finance.yahoo.com
28th of March 2024
Apogee Stock Rallies 95.6 percent in a Month Heres Why at finance.yahoo.com
22nd of March 2024
FibroGen, Inc.s Share Price Boosted 35 percent But Its Business Prospects Need A Lift Too at simplywall.st
20th of March 2024
Crinetics Up as Second Acromegaly Study Meets Goals at finance.yahoo.com
12th of March 2024
Acadia Down as Schizophrenia Study on Nuplazid Fails at finance.yahoo.com
26th of February 2024
FibroGen GAAP EPS of -0.57 misses by 0.14, revenue of 27.14M misses by 11.64M at seekingalpha.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards FibroGen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, FibroGen's short interest history, or implied volatility extrapolated from FibroGen options trading.
Check out FibroGen Backtesting and FibroGen Hype Analysis. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for FibroGen Stock analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (2.92) | Revenue Per Share 1.518 | Quarterly Revenue Growth (0.21) | Return On Assets (0.36) |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.